Nautilus Biotechnology Inc
NAUT
$2.17-3.56%
End of day · as of Oct 13, 2026, 4:45 AM ET
Mkt cap
$103.44M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2026-06-30)
$190,000
EPS (H1 2026)
$-0.23
Gross Margin (qtr ended 2026-06-30)
92.11%
Profit Margin (qtr ended 2026-06-30)
-7615.26%
Beta
1.25
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Nautilus Biotechnology Inc (NAUT) is a biotechnology company listed on US.
Latest reported NAUT revenue for 2026-06-30 was $190.0K. Net income was -$14.5M. NAUT currently screens at market cap $103.4M.
Use this NAUT research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full NAUT income, balance, and cash tables.
Nautilus Biotechnology Inc (NAUT) is a biotechnology company in the Healthcare sector.
Latest cached Nautilus Biotechnology Inc (NAUT) revenue for Jun 30, 2026 was $190.0K. Net income was -$14.5M. Statements: https://lician.com/financials/naut
Nautilus Biotechnology Inc (NAUT) market capitalization is $103.4M on the latest cached snapshot.
Nautilus Biotechnology Inc (NAUT) cached previous close $2.25; day range $2.16 – $2.17; volume 13,277,951. Session quote: https://lician.com/quote/naut
Nautilus Biotechnology Inc (NAUT) latest cached earnings event is "NAUT earnings" on Jul 30, 2026. Earnings calendar: https://lician.com/earnings